The ongoing legal battles surrounding the abortion pill mifepristone have intensified as the Supreme Court weighs arguments over telehealth access and mail-order prescriptions. Several states are pushing for restrictions, with appeals courts issuing conflicting rulings that have resulted in chaos and uncertainty among healthcare providers. Advocates for abortion rights assert that these medications save lives, while conservative groups argue for greater control and safety measures. Recently, the Supreme Court temporarily restored access to mifepristone through telehealth and mail services, a move that has reignited debates about the implications of such rulings ahead of upcoming elections. As the landscape shifts, both sides prepare for further legal skirmishes that could shape the future of abortion access in the U.S.